Related references
Note: Only part of the references are listed.Consistent Alterations of Circulating Matrix Metalloproteinases Levels in Untreated Hypertensives and in Spontaneously Hypertensive Rats: A Relevant Pharmacological Target
Vanessa Fontana et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2011)
Sodium nitrite downregulates vascular NADPH oxidase and exerts antihypertensive effects in hypertension
Marcelo F. Montenegro et al.
FREE RADICAL BIOLOGY AND MEDICINE (2011)
Matrix metalloproteinase 9 gene haplotypes affect left ventricular hypertrophy in hypertensive patients
Riccardo Lacchini et al.
CLINICA CHIMICA ACTA (2010)
Interethnic Differences in the Distribution of Matrix Metalloproteinases Genetic Polymorphisms Are Consistent with Interethnic Differences in Disease Prevalence
Riccardo Lacchini et al.
DNA AND CELL BIOLOGY (2010)
Matrix Metalloproteinase Inhibition Improves Cardiac Dysfunction and Remodeling in 2-Kidney, 1-Clip Hypertension
Elen Rizzi et al.
JOURNAL OF CARDIAC FAILURE (2010)
Imbalance between matrix metalloproteinases and tissue inhibitor of metalloproteinases in hypertensive vascular remodeling
Michele M. Castro et al.
MATRIX BIOLOGY (2010)
Increased circulating levels of matrix metalloproteinase (MMP)-8, MMP-9, and pro-inflammatory markers in patients with metabolic syndrome
Flavia M. Goncalves et al.
CLINICA CHIMICA ACTA (2009)
Assessment of matrix metalloproteinase (MMP)-2, MMP-8, MMP-9, and their inhibitors, the tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 in obese children and adolescents
Vanessa A. Belo et al.
CLINICAL BIOCHEMISTRY (2009)
Racial Differences in Incident Heart Failure among Young Adults
Kirsten Bibbins-Domingo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Nitrite or sildenafil, but not BAY 41-2272, blunt acute pulmonary embolism-induced increases in circulating matrix metalloproteinase-9 and oxidative stress
Carlos A. Dias-Junior et al.
THROMBOSIS RESEARCH (2009)
Differences in the Incidence of Congestive Heart Failure by Ethnicity - The Multi-Ethnic Study of Atherosclerosis
Hossein Bahrarni et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
Metalloproteinase inhibition ameliorates hypertension and prevents vascular dysfunction and remodeling in renovascular hypertensive rats
Michele A. Castro et al.
ATHEROSCLEROSIS (2008)
Inverse relationship between markers of nitric oxide formation and plasma matrix metalloproteinase-9 levels in healthy volunteers
Caroline Demacq et al.
CLINICA CHIMICA ACTA (2008)
Functional polymorphisms in the promoter of the matrix metalloproteinase-9 (MMP-9) gene are not linked with significant plasma MMP-9 variations in healthy subjects
Caroline Demacq et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2008)
Lercanidipine decreases vascular matrix metalloproteinase-2 activity and protects against vascular dysfunction in diabetic rats
Marcio L. L. Martinez et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Serial measurements of whole blood nitrite in an intensive care setting
Eva S. Kehmeier et al.
FREE RADICAL BIOLOGY AND MEDICINE (2008)
Anti-inflammatory effects of atorvastatin: Modulation by the T-786C polymorphism in the endothelial nitric oxide synthase gene
Debora C. Souza-Costa et al.
ATHEROSCLEROSIS (2007)
Vascular dysfunction and reduced circulating endothelial progenitor cells in young healthy UK South Asian men
Cliona Murphy et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Absolute and attributable risks of cardiovascular disease incidence in relation to optimal and borderline risk factors - Comparison of African American with white subjects - Atherosclerosis risk in communities study
Atsushi Hozawa et al.
ARCHIVES OF INTERNAL MEDICINE (2007)
Protective effects of atorvastatin in rat models of acute pulmonary embolism: Involvement of matrix metalloproteinase-9
Debora C. Souza-Costa et al.
CRITICAL CARE MEDICINE (2007)
Rapid separation of serum does not avoid artificially higher matrix metalloproteinase (MMP)-9 levels in serum versus plasma
Raquel F. Gerlach et al.
CLINICAL BIOCHEMISTRY (2007)
Low-dose intravenous nitrite improves hemodynamics in a canine model of acute pulmonary thromboembolism
Carlos A. C. Dias-Junior et al.
FREE RADICAL BIOLOGY AND MEDICINE (2006)
Clinical evidence for lead-induced inhibition of nitric oxide formation
Fernando Barbosa et al.
ARCHIVES OF TOXICOLOGY (2006)
Nitrite as a vascular endocrine nitric oxide reservoir that contributes to hypoxic signaling, cytoprotection, and vasodilation
Mark T. Gladwin et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
eNOS gene T-786C polymorphism modulates atorvastatin-induced increase in blood nitrite
Sabrina Nagassaki et al.
FREE RADICAL BIOLOGY AND MEDICINE (2006)
Relationship between systemic nitric oxide metabolites and cyclic GMP in healthy male volunteers
I. F. Metzger et al.
ACTA PHYSIOLOGICA (2006)
Matrix metalloproteinase-9 activity in plasma correlates with plasma and whole blood lead concentrations
Fernando Barbosa et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2006)
Plasma nitrite concentrations reflect the degree of endothelial dysfunction in humans
P Kleinbongard et al.
FREE RADICAL BIOLOGY AND MEDICINE (2006)
Erythrocytes are the major intravascular storage sites of nitrite in human blood
A Dejam et al.
BLOOD (2005)
Consistent interethnic differences in the distribution of clinically relevant endothelial nitric oxide synthase genetic polymorphisms
AS Marroni et al.
NITRIC OXIDE-BIOLOGY AND CHEMISTRY (2005)
State of disparities in cardiovascular health in the United States
GA Mensah et al.
CIRCULATION (2005)
The biochemistry of nitric oxide, nitrite, and hemoglobin: Role in blood flow regulation
MT Gladwin et al.
FREE RADICAL BIOLOGY AND MEDICINE (2004)
Reduction of nitrite to nitric oxide during ischemia protects against myocardial ischemia-reperfusion damage
A Webb et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Weight loss and race modulate nitric oxide metabolism in overweight women
CP Fenster et al.
FREE RADICAL BIOLOGY AND MEDICINE (2004)
Regulation of matrix metalloproteinases and their inhibitors in the left ventricular myocardium of patients with aortic stenosis
J Fielitz et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2004)
Race-specific differences in endothelial function - Predisposition of African Americans to vascular diseases
L Kalinowski et al.
CIRCULATION (2004)
Nitric oxide increases the decay of matrix metalloproteinase 9 mRNA by inhibiting the expression of mRNA-stabilizing factor HuR
ES Akool et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Effect of short-term hormone therapy on oxidative stress and endothelial function in African American and Caucasian postmenopausal women
RW Ke et al.
FERTILITY AND STERILITY (2003)
Ethnicity affects vasodilation, but not endothelial tissue plasminogen activator release, in response to bradykinin
DA Rosenbaum et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
Nitric oxide inhibition increases aortic wall matrix metalloproteinase-9 expression
MJ Eagleton et al.
JOURNAL OF SURGICAL RESEARCH (2002)
Effects of ethnicity on the distribution of clinically relevant endothelial nitric oxide variants
JE Tanus-Santos et al.
PHARMACOGENETICS (2001)
Nitric oxide inhibition increases matrix metalloproteinase-9 expression by rat aortic smooth muscle cells in vitro
GR Upchurch et al.
JOURNAL OF VASCULAR SURGERY (2001)
Efficacy of different drug classes used to initiate antihypertensive treatment in black subjects -: Results of a randomized trial in Johannesburg, South Africa
P Sareli et al.
ARCHIVES OF INTERNAL MEDICINE (2001)
Nitric oxide modulates expression of matrix metalloproteinase-9 in rat mesangial cells
W Eberhardt et al.
KIDNEY INTERNATIONAL (2000)
Share Paper
